IL-13 induces CD34+ cells isolated from G-CSF mobilized blood to differentiate in vitro into potent antigen presenting cells

Journal of Immunological Methods

Volumn 208, Issue 2, 1997, Pages 117-129

  Lopez, M ^a   Amorim, L ^a   Gane, P ^a   Cristoph, A ^b   Bardinet, D ^a   Abina, A M ^a   Minty, A ^c   Bernard, J ^b  

^a INSERM   (France)

^b INSTITUT JEAN GODINOT   (France)

^c SANOFI   (France)

Author keywords

CD34+ cells; Dendritic cells; IL 13; TNF

Indexed keywords

B7 ANTIGEN; CD1 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD40 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 13; T LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; BREAST CANCER; CELL CULTURE; CONTROLLED STUDY; DENDRITIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; ANTIGENS, CD34; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-13; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031455822     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(97)00133-6     Document Type: Article

References (33)

1. Callard R.E., Matthews D.J., Hibbert L. IL-4 and IL-13 receptors: Are they one and the same? Immunol. Today. 17:1996;108.
2. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF α cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258.
3. Caux C., Liu Y.L., Banchereau J. Recent advances in the study of DCs and follicular DCs. Immunol. Today. 16:1995;2.
4. De Waal Malefyt R., Figdor C.G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., Dang W., Zurawski G., de Vries J.E. Effects of IL-13 on phenotype, cytokine production and cytotoxic function of human monocytes. J. Immunol. 151:1993;6370.
5. Flamand V., Sornasse T., Thielemans K., Demanet C., Bakkus M., Bazin H., Thielemans F., Leo O., Urbain J., Moser M. Murine dendritic cells pulsed in vitro with tumour antigen induce tumour resistance in vivo. Eur. J. Immunol. 42:1994;605.
6. Grabbe S., Beissert S., Schwarz T., Granstein R. Dendritic cells as initiators of tumor immune responses: A possible strategy for tumor immunotherapy? Immunol. Today. 16:1995;117.
7. Hsu F.J., Benike C., Fagnoni F., Liles T.M., Czerwinski D., Taidi B., Engleman E.G., Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2:1996;52.
8. Inaba K., Metlay J.P., Crowley M.T., Steinman R.M. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T-cells in situ. J. Exp. Med. 172:1990;631.
9. Ishii E., Watanabe S. Biochemistry and biology of the Langerhans cell. Hematol. Oncol. Clin. North Am. 1:1987;99.
10. Lopez M., Martinache C., Canepa S., Chokri M., Scotto F., Bartholeyns J. Autologous lymphocytes prevent the death of monocytes in culture and promote, as do GM-CSF, IL-3 and M-CSF, their differentiation into macrophages. J. Immunol. Methods. 159:1993;29.
11. McKenzie A.N.J., Culpepper J.A., de Waal Malefyt R., Briere F., Punnonen J., Aversa G., Sato A., Dang W., Cocks B.G., Menon S., de Vries J.E., Banchereau J., Zurawski G. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA. 90:1993;3735.
12. Minty A., Chalon P., Derocq J.M., Dumont X., Guillemot J.C., Kaghad M., Labit C., Leplatois P., Liauzun P., Milous B., Minty C., Casellas P., Loison G., Lupker J., Shire D., Ferrara P., Caput D. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 362:1993;248.
13. O'Doherty U., Peng M., Gezelter S., Swiggard W.J., Betjes M., Bhardwaj N., Steinman R.M. Human blood contains two subsets of DCs, one immunologically mature and the other immature. Immunology. 82:1994;487.
14. Paglia P., Chiodini C.R., Colombo M.P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T-lymphocytes against tumor antigen in vivo. J. Exp Med. 183:1996;317.
15. Peters J.H., Gieseler R., Thiele B., Steinbach F. Dendritic cells: From ontogenetic orphans to myelomonocytic descendants. Immunul. Today. 17:1996;273.
16. Piemonti L., Bernasconi S., Luini W., Trobonjaca Z., Minty A., Allavena P., Mantovani A. IL-13 supports differentiation of DCs from circulating precursors in concert with GM-CSF. Eur. Cytokine Netw. 6:1995;245.
17. S.A. Porcelli, The CD1 family: A third lineage of antigen-presenting molecules. Advances Immunol. 59 (1995).
18. Reid C.D.L., Fryer P.R., Clifford C., Kirk A., Tikerpae J., Knight S.C. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human marrow and peripheral blood. Blood. 76:1990;1139.
19. + progenitors in human bone marrow. Immunology. 149:1992;2681.
20. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:1994;83.
21. + hematopoietic precursor cells. Blood. 87:1996;535.
22. Rossi G., Heveker N., Thiele B., Gelderblom H., Steinbach F. Development of a Langerhans cell phenotype from peripheral blood monocytes. Immunol. Lett. 31:1992;189.
23. Sakamoto O., Hashiyama M., Minty A., Ando M., Suda T. Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage. Blood. 85:1995;3487.
24. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured DCs is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α J. Exp. Med. 179:1994;1109.
25. Santiago-Schwarz F., Belilos E., Diamond B., Carsons S.E. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into DCs and macrophages. J. Leuk. Biol. 52:1992;274.
26. + blood progenitors for anticancer therapy. Exp. Hematol. 23:1995;1463.
27. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271.
28. + hematopoietic progenitor cells. Blood. 87:1996;1292.
29. Szabolcs P., Moore M.A.S., Young J.W. Expansion of immuno-stimulatory DCs among the myeloid progeny of human CD34+ bone marrow precursors with c-kit ligand, granulocyte-macrophage colony-stimulating factor and TNF α J. Immunol. 154:1995;5851.
30. Thomas R., Lipsky P.E. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen presenting cells. J. Immunol. 153:1994;4016.
31. Weissman D., Li Y., Ananworanich J., Zhou L.J., Adelsberger J., Tedder T.F., Baseler M., Fauci A.S. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Immunology. 92:1995;826.
32. Zagury J.F., Bernard J., Achour A., Atsguen A., Lachcar A., Fall L., Carelli C., Issing W., Mbika J.P., Picard O., Carlotti M., Callebaut I., Mornon J.P., Burny A., Feldman M., Bizzini B., Zagury D. Identification of CD4 and MHC functional peptide sites and their homology witk HIV-1 gp120 oligopeptides: Role in AIDS pathogenesis. Proc. Natl. Acad. Sci. USA. 90:1993;7573.
33. Zitvogel L., Mayordomo J.I., Tjandrawan T., DeLeo A.B., Clarke M.R., Lotze M.T., Storkus W.J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T-cells, B7 costimulation and T helper cell1-associated cytokines. J. Exp. Med. 183:1996;87.